首页 > 最新文献

Chinese Journal of Clinical Hepatology最新文献

英文 中文
IDDF2022-ABS-0120 Hepatocyte apoptosis fragment product cytokeratin-18 M30 and non-alcoholic steatohepatitis risk prediction: an international registry study 肝细胞凋亡片段产物细胞角蛋白- 18m30与非酒精性脂肪性肝炎风险预测:一项国际登记研究
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.99
Huai Zhang, Rafael S Rios, J. Boursier, R. Anty, W. Chan, J. George, Y. Yılmaz, V. Wong, S. Sookoian, Jian-Gao Fan, J. Dufour, G. Papatheodoridis, Li Chen, J. Schattenberg, Jun-Ping Shi, Liang Xu, G. Wong, C. Pirola, Naomi F Lange, M. Papatheodoridi, Y. Mi, Yu-Jie Zhou, C. Byrne, G. Targher, G. Feng, M. Zheng
{"title":"IDDF2022-ABS-0120 Hepatocyte apoptosis fragment product cytokeratin-18 M30 and non-alcoholic steatohepatitis risk prediction: an international registry study","authors":"Huai Zhang, Rafael S Rios, J. Boursier, R. Anty, W. Chan, J. George, Y. Yılmaz, V. Wong, S. Sookoian, Jian-Gao Fan, J. Dufour, G. Papatheodoridis, Li Chen, J. Schattenberg, Jun-Ping Shi, Liang Xu, G. Wong, C. Pirola, Naomi F Lange, M. Papatheodoridi, Y. Mi, Yu-Jie Zhou, C. Byrne, G. Targher, G. Feng, M. Zheng","doi":"10.1136/gutjnl-2022-iddf.99","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.99","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76441354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0125 Comparative burden of metabolic dysfunction nafld in lean. A meta analysis 瘦人代谢功能障碍的比较负担。meta分析
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.100
C. Ng, K. Chan, A. Tang, P. Phang, M. Siddiqui, A. Sanyal, M. Muthiah, M. Noureddin
{"title":"IDDF2022-ABS-0125 Comparative burden of metabolic dysfunction nafld in lean. A meta analysis","authors":"C. Ng, K. Chan, A. Tang, P. Phang, M. Siddiqui, A. Sanyal, M. Muthiah, M. Noureddin","doi":"10.1136/gutjnl-2022-iddf.100","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.100","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84596383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0046 Social life and financial barriers of thai HCC survivors: a cross-sectional survey 泰国HCC幸存者的社会生活和经济障碍:一项横断面调查
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.91
P. Wanchaijiraboon, Naiyarat Prakongsook, K. Pongpirul, C. Chumsri, P. Kantagowit, Phanupong Phutrakook, P. Tangkijvanich, W. Sukeepaisarnjareon
{"title":"IDDF2022-ABS-0046 Social life and financial barriers of thai HCC survivors: a cross-sectional survey","authors":"P. Wanchaijiraboon, Naiyarat Prakongsook, K. Pongpirul, C. Chumsri, P. Kantagowit, Phanupong Phutrakook, P. Tangkijvanich, W. Sukeepaisarnjareon","doi":"10.1136/gutjnl-2022-iddf.91","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.91","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85223357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0071 EUS guided coil and glue for gastric varices- one therapy to rule them all? EUS引导胃静脉曲张线圈和胶水-一种治疗方法可以治疗所有静脉曲张?
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.94
Z. Sharma, R. Puri, S. Bhagat, A. Kathuria
{"title":"IDDF2022-ABS-0071 EUS guided coil and glue for gastric varices- one therapy to rule them all?","authors":"Z. Sharma, R. Puri, S. Bhagat, A. Kathuria","doi":"10.1136/gutjnl-2022-iddf.94","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.94","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90914031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0185 Tinospora cordifolia induced liver injury during covid-19 pandemic 新型冠状病毒大流行期间cordifolia Tinospora诱导的肝损伤
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.115
Sowmya Iyengar, A. Kulkarni, Mithun Sharma, D. Nageshwar Reddy, P. Rao
IDDF2022-ABS-0185 Table 1Clinical characteristics of patients with Giloy-induced liver injuryCharacteristics Number of patients (Total-16 patients) Gender Male 7 (43.75%) Female 9 (56.25%) Age (mean ± SD) 48.3±14 years Presentation type Acute hepatitis 6 (37.5%) ACLF 10 (62.5%) Mean duration for symptom onset after consumption of giloy 84.3±35 days Mean BMI 23.23±3 kg/m2 Comorbidities Type 2 diabetes 9 (56.25%) Interstitial lung disease (on inhalational steroids) 2 (12.5%) Hypertension 1 (6.25%) None 5 (31.25%) NAFLD 2 (6.25%) Symptoms Jaundice 16 (100%) Ascites 8 (50%) Fatigue 12 (75%) Pruritus 4 (25%) Liver function tests Peak total bilirubin (Mean ± SD) 17 ± 9.4 mg/dl Peak ALT (mean ± SD) 365± 219 U/L Peak AST (mean ± SD) 558 ± 475 U/L Peak ALP (mean ± SD) 186 ± 114 U/L Peak serum IgG (mean ± SD) 2400 ± 1213 mg/dl Peak INR (mean ± SD) 2.63 ± 1.05 AIH serology ANA 1(6.25%) ASMA - Anti LKM1 - AMA - Seronegative (biopsy proven) - Liver biopsy 10 (62.5) Drug induced liver injury 5 (31.25%) Features of AIH 5 (31.25%) Treatment N-Acetyl Cysteine infusion+Ademetionine 3 (18.75%) Steroids 10 (62.5%) Plasma Exchange 3 (18.75%) Outcome Alive 16 (100%) One listed for liver transplant Mean duration for recovery 37 ± 16 days IDDF2022-ABS-0185 Figure 1ConclusionsGiloy, a commonly used immunity booster, can produce drug-induced liver injury, which often mimics autoimmune hepatitis and responds to steroids.
表1吉洛伊致肝损伤患者的临床特征特征患者人数(共16例)性别男7(43.75%)女9(56.25%)年龄(平均±SD) 48.3±14岁表现类型急性肝炎6 (37.5%)ACLF 10(62.5%)吉洛伊消耗后症状出现的平均持续时间84.3±35天平均BMI 23.23±3 kg/m2合并症2型糖尿病9(56.25%)肺间质性疾病(吸入性类固醇)2(12.5%)高血压1 (6.25%)没有5(31.25%)非酒精性脂肪肝2例(6.25%)症状16(100%)腹水黄疸8(50%)疲劳12(75%)瘙痒4(25%)肝功能测试峰值总胆红素(平均数±标准差)17±9.4 mg / dl峰值ALT(平均数±标准差)365±219 U / L峰值AST(平均数±标准差)558±475 U / L峰值高山(平均数±标准差)186±114 U / L峰值血清免疫球蛋白(平均±SD) 2400±1213 mg / dl INR峰值(平均数±标准差)2.63±1.05 AIH血清学安娜1 (6.25%)ASMA -反LKM1 AMA -血清反应阴性的(活检证实)- 10(62.5)肝脏活组织检查药物诱导肝损伤5(31.25%) AIH 5特点(31.25%)治疗方法n -乙酰半胱氨酸输注+腺苷- 3(18.75%)类固醇10(62.5%)血浆置换3(18.75%)预后存活16(100%)1例肝移植患者平均恢复时间37±16天IDDF2022-ABS-0185图1结论giloy是常用的免疫增强剂,可引起药物性肝损伤,通常与自身免疫性肝炎相似,对类固醇有应答。
{"title":"IDDF2022-ABS-0185 Tinospora cordifolia induced liver injury during covid-19 pandemic","authors":"Sowmya Iyengar, A. Kulkarni, Mithun Sharma, D. Nageshwar Reddy, P. Rao","doi":"10.1136/gutjnl-2022-iddf.115","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.115","url":null,"abstract":"IDDF2022-ABS-0185 Table 1Clinical characteristics of patients with Giloy-induced liver injuryCharacteristics Number of patients (Total-16 patients) Gender Male 7 (43.75%) Female 9 (56.25%) Age (mean ± SD) 48.3±14 years Presentation type Acute hepatitis 6 (37.5%) ACLF 10 (62.5%) Mean duration for symptom onset after consumption of giloy 84.3±35 days Mean BMI 23.23±3 kg/m2 Comorbidities Type 2 diabetes 9 (56.25%) Interstitial lung disease (on inhalational steroids) 2 (12.5%) Hypertension 1 (6.25%) None 5 (31.25%) NAFLD 2 (6.25%) Symptoms Jaundice 16 (100%) Ascites 8 (50%) Fatigue 12 (75%) Pruritus 4 (25%) Liver function tests Peak total bilirubin (Mean ± SD) 17 ± 9.4 mg/dl Peak ALT (mean ± SD) 365± 219 U/L Peak AST (mean ± SD) 558 ± 475 U/L Peak ALP (mean ± SD) 186 ± 114 U/L Peak serum IgG (mean ± SD) 2400 ± 1213 mg/dl Peak INR (mean ± SD) 2.63 ± 1.05 AIH serology ANA 1(6.25%) ASMA - Anti LKM1 - AMA - Seronegative (biopsy proven) - Liver biopsy 10 (62.5) Drug induced liver injury 5 (31.25%) Features of AIH 5 (31.25%) Treatment N-Acetyl Cysteine infusion+Ademetionine 3 (18.75%) Steroids 10 (62.5%) Plasma Exchange 3 (18.75%) Outcome Alive 16 (100%) One listed for liver transplant Mean duration for recovery 37 ± 16 days IDDF2022-ABS-0185 Figure 1ConclusionsGiloy, a commonly used immunity booster, can produce drug-induced liver injury, which often mimics autoimmune hepatitis and responds to steroids.","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88943750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0242 Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C 接受泛型直接作用抗病毒药物治疗丙型肝炎患者的多重药物相互作用风险可能与安全性相关
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.125
J. Turnes, A. García-Herola, R. Morillo, M. Méndez, M. Rueda, Cándido Hernández, A. Sicras-Mainar
{"title":"IDDF2022-ABS-0242 Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C","authors":"J. Turnes, A. García-Herola, R. Morillo, M. Méndez, M. Rueda, Cándido Hernández, A. Sicras-Mainar","doi":"10.1136/gutjnl-2022-iddf.125","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.125","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82649284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0243 Incidence of liver cancer by histological subtypes in 2020: a global study 2020年肝癌组织学亚型发病率:一项全球研究
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.126
Junjie Huang, Veeleah Lok, Lin Zhang, D. Lucero‐Prisno, Wanghong Xu, Z. Zheng, Edmar Elcarte, M. Withers, Martin C. S. Wong
{"title":"IDDF2022-ABS-0243 Incidence of liver cancer by histological subtypes in 2020: a global study","authors":"Junjie Huang, Veeleah Lok, Lin Zhang, D. Lucero‐Prisno, Wanghong Xu, Z. Zheng, Edmar Elcarte, M. Withers, Martin C. S. Wong","doi":"10.1136/gutjnl-2022-iddf.126","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.126","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86254875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0281 Umbilico-bilious fistula-a diagnostic challenge 脐胆管瘘-诊断挑战
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.134
Parveen Kumar, V. Manchanda, M. Sengar
{"title":"IDDF2022-ABS-0281 Umbilico-bilious fistula-a diagnostic challenge","authors":"Parveen Kumar, V. Manchanda, M. Sengar","doi":"10.1136/gutjnl-2022-iddf.134","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.134","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76715960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IDDF2022-ABS-0117 A retrospective study into etiology, clinical outcomes and prognostic factors of severe acute liver injury in hong kong 香港严重急性肝损伤的病因、临床结局和预后因素回顾性研究
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.98
Ka-Yan Gloria Chan
{"title":"IDDF2022-ABS-0117 A retrospective study into etiology, clinical outcomes and prognostic factors of severe acute liver injury in hong kong","authors":"Ka-Yan Gloria Chan","doi":"10.1136/gutjnl-2022-iddf.98","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.98","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79892950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
IDDF2022-ABS-0182 Comparing the diagnostic accuracy of renal resistive index and urine neutrophil gelatinase-associated lipocalin (NGAL) in differentiating type of acute kidney injury in decompensated cirrhosis 肾抵抗指数与尿中性粒细胞明胶酶相关脂钙蛋白(NGAL)鉴别失代偿期肝硬化急性肾损伤类型的诊断准确性比较
Pub Date : 2022-09-01 DOI: 10.1136/gutjnl-2022-iddf.114
Roshan George, Ajay Kumar, U. Sonika
{"title":"IDDF2022-ABS-0182 Comparing the diagnostic accuracy of renal resistive index and urine neutrophil gelatinase-associated lipocalin (NGAL) in differentiating type of acute kidney injury in decompensated cirrhosis","authors":"Roshan George, Ajay Kumar, U. Sonika","doi":"10.1136/gutjnl-2022-iddf.114","DOIUrl":"https://doi.org/10.1136/gutjnl-2022-iddf.114","url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79710446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Journal of Clinical Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1